USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a ...

Alzheimer's disease, the most common form of dementia, is responsible for tens of millions of cases around the world. Jens Kalaene/dpa Following tests on apes and mice, a team of University of New ...

The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients. NEW HAVEN, CT / ACCESS Newswire / December 5, 2025 / ...

Tree frog gut bacteria eliminated 100% of colorectal tumors in mice, but human cancer treatment faces safety hurdles and ...

A new experimental vaccine for nipah virus has successfully completed its first human trial. The vaccine was well-tolerated ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Learn how clinical operations leaders can build technology adoption, transform workflows, and cultivate digitally savvy ...